-
PHXM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
-
Insider
- Institutional
- Shorts
PHAXIAM Therapeutics (PHXM)
Company Profile
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 10 |
Opened positions | 6 |
Closed positions | 2 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 82.75 mm |
Total shares | 653.01 k |
Total puts | 0.00 |
Total calls | 400.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Biotechnology Value Fund L P | 517.24 k | $0.00 |
JustInvest | 24.27 k | $18.69 mm |
Baader Bank | 24.00 k | $14.72 mm |
Mariner | 23.90 k | $18.41 mm |
SNEX StoneX | 17.30 k | $13.00 k |
Citadel Advisors | 16.61 k | $12.12 mm |
Millennium Management | 12.07 k | $8.81 mm |
Group One Trading | 10.59 k | $7.73 mm |
Asset Dedication | 4.00 k | $4.00 k |
Ikarian Capital | 3.02 k | $2.26 mm |